Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2026-01-10 @ 8:18 PM
Study NCT ID:
NCT01141751
Status:
COMPLETED
Last Update Posted:
2014-07-14
First Post:
2010-06-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization: